Skip to main content

Drug Shortages

Featured Article
“Working with the private sector, HHS is taking a significant step to rebuild our domestic ability to protect ourselves from health threats by utilizing American-made ingredients and creating new…
Doug Zurawski, PharmD, senior vice president, Clinical Strategy, Kit Check, discusses the results of a recent hospital pharmacy survey and explains the major impact drug shortages have on hospitals,…

Insights

Doug Zurawski, PharmD, senior vice president, Clinical Strategy, Kit Check, discusses the results of a recent hospital pharmacy survey and explains the major impact drug shortages have on hospitals, and why hospital pharmacy leaders need to begin to…
Douglas Jennings, PharmD, discusses some of the major decisions hospitals are faced with due to drug shortages in the wake of COVID-19, and explains why he believes pharmacists are going to have to get very creative in how they practice.
Sahar Swidan, PharmD, discusses the impact the pandemic has had on drug shortages and provides insight on our country's dependency on foreign drug products.
According to Douglas Jennings, PharmD, “stockpiles of key medications needed to care for patients infected with SARS CoV 2 are dwindling, forcing many hospitals to ration remaining supplies and scramble to procure alternative therapies.”

Interactive Features

Michael Ganio, PharmD, senior director, pharmacy practice and quality, ASHP, discusses 2020 drug shortage trends, highlights how NDMA exposure can be improved during the manufacturing process, and provides a future prediction on how he sees pharmacy…
Editorial board member Matthew Grissinger, RPh, FISMP, FASCP, discusses drug shortages and their impact on the entire care team, and also provides a 5-year prediction on the future of health care.
Back to Top